Correlation Between HCW Biologics and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and AbbVie Inc, you can compare the effects of market volatilities on HCW Biologics and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and AbbVie.

Diversification Opportunities for HCW Biologics and AbbVie

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between HCW and AbbVie is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of HCW Biologics i.e., HCW Biologics and AbbVie go up and down completely randomly.

Pair Corralation between HCW Biologics and AbbVie

Given the investment horizon of 90 days HCW Biologics is expected to generate 21.31 times more return on investment than AbbVie. However, HCW Biologics is 21.31 times more volatile than AbbVie Inc. It trades about 0.13 of its potential returns per unit of risk. AbbVie Inc is currently generating about -0.03 per unit of risk. If you would invest  44.00  in HCW Biologics on August 30, 2024 and sell it today you would earn a total of  6.00  from holding HCW Biologics or generate 13.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  AbbVie Inc

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

HCW Biologics and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and AbbVie

The main advantage of trading using opposite HCW Biologics and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind HCW Biologics and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios